Powered by: Motilal Oswal
2025-01-29 12:06:01 pm | Source: Accord Fintech
Valencia Nutrition touches the roof on getting nod to acquire additional 49% stake in Zion Beverages
Valencia Nutrition touches the roof on getting nod to acquire additional 49% stake in Zion Beverages

Valencia Nutrition is locked its upper circuit limit at Rs. 45.51, up by 2.16 points or 4.98% from its previous closing of Rs. 43.35 on the BSE.

The scrip opened at Rs. 45.51 and has touched a high and low of Rs. 45.51 and Rs. 45.51 respectively. So far 3000 shares were traded on the counter.

The BSE group 'TS' stock of face value Rs. 10 has touched a 52 week high of Rs. 64.95 on 30-Sep-2024 and a 52 week low of Rs. 27.36 on 30-May-2024.

Last one week high and low of the scrip stood at Rs. 45.51 and Rs. 39.28 respectively. The current market cap of the company is Rs. 63.54 crore.

The promoters holding in the company stood at 64.87%, while Non-Institutions held 35.13% stake in the company.  

Valencia Nutrition has received approval from Board of Directors for acquisition of an additional 49% stake in Zion Beverages for Rs 98,00,000, to be paid in one or more tranches.

This additional stake acquisition is expected to have a significant impact on the Company by further consolidating its foothold in the beverage sector. The transaction will provide Valencia Nutrition with greater control and influence over Zion Beverages’ operations, thereby enabling enhanced operational synergies, improved strategic alignment, and accelerated growth prospects. 

The Zion Beverages is engaged in the business of manufacturing and trading of Beverages. The Company had acquired a 50% stake in Zion Beverages on November 28, 2024.

Valencia Nutrition is engaged in the business of developing, manufacturing, sale & distribution of nutraceutical products.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here